Next Article in Journal
Therapeutic Interchange of Parenteral Anticoagulants: Challenges for Pharmacy and Therapeutics Committees
Next Article in Special Issue
Advances in Drug Design Based on the Amino Acid Approach: Taurine Analogues for the Treatment of CNS Diseases
Previous Article in Journal
Coupling Aptamers to Short Interfering RNAs as Therapeutics
Previous Article in Special Issue
Targeting the Large Subunit of Human Ribonucleotide Reductase for Cancer Chemotherapy
Open AccessReview

Anti-Inflammatory Drug Design Using a Molecular Hybridization Approach

Lapdesf, Laboratory of Drug Design, Department of Drugs and Medicines, School of Pharmaceutical Sciences, University of São Paulo State (UNESP), Rodovia Araraquara-Jaú, km 1, Araraquara, SP, Cep. 14.802-901, Brazil
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2011, 4(11), 1450-1474; https://doi.org/10.3390/ph4111450
Received: 8 August 2011 / Revised: 20 October 2011 / Accepted: 20 October 2011 / Published: 27 October 2011
(This article belongs to the Special Issue Advances in Drug Design)
The design of new drugs with better physiochemical properties, adequate absorption, distribution, metabolism, and excretion, effective pharmacologic potency and lacking toxicity remains is a challenge. Inflammation is the initial trigger of several different diseases, such as Alzheimer’s disease, asthma, atherosclerosis, colitis, rheumatoid arthritis, depression, cancer; and disorders such as obesity and sexual dysfunction. Although inflammation is not the direct cause of these disorders, inflammatory processes often increase related pain and suffering. New anti-inflammatory drugs developed using molecular hybridization techniques to obtain multiple-ligand drugs can act at one or multiple targets, allowing for synergic action and minimizing toxicity. This work is a review of new anti-inflammatory drugs developed using the molecular modification approach. View Full-Text
Keywords: anti-inflammatory; hybridization; multiple-ligands; mutual prodrug anti-inflammatory; hybridization; multiple-ligands; mutual prodrug
Show Figures

Graphical abstract

MDPI and ACS Style

Bosquesi, P.L.; Melo, T.R.F.; Vizioli, E.O.; Santos, J.L.; Chung, M.C. Anti-Inflammatory Drug Design Using a Molecular Hybridization Approach. Pharmaceuticals 2011, 4, 1450-1474.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop